HR 4534
118th Congress
House
Health
Cancer
Cardiovascular and respiratory health
Government studies and investigations
Health care coverage and access
Health promotion and preventive care
Medical research
Medical tests and diagnostic methods
Women's health
Women and Lung Cancer Research and Preventive Services Act of 2024
Introduced: July 11, 2023
Introduced by:
Boyle, Brendan F.
Democratic
· Pennsylvania
See on congress.gov
Everywhere this bill has been
16 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 17, 2024
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Dec 16, 2024
Motion to reconsider laid on the table Agreed to without objection.
Dec 16, 2024
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (consideration: CR H7166)
Dec 16, 2024
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (consideration: CR H7166)
Dec 16, 2024
DEBATE - The House proceeded with forty minutes of debate on H.R. 4534.
Dec 16, 2024
Considered under suspension of the rules. (consideration: CR H7166-7167)
Dec 16, 2024
Mr. Bucshon moved to suspend the rules and pass the bill, as amended.
Jul 30, 2024
Placed on the Union Calendar, Calendar No. 520.
Jul 30, 2024
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-622.
Jun 12, 2024
Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0.
Jun 12, 2024
Committee Consideration and Mark-up Session Held
May 16, 2024
Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 21 - 0.
May 16, 2024
Subcommittee Consideration and Mark-up Session Held
Jul 14, 2023
Referred to the Subcommittee on Health.
Jul 11, 2023
Referred to the House Committee on Energy and Commerce.
Jul 11, 2023
Introduced in House
Plain-English summary
Women and Lung Cancer Research and Preventive Services Act of 2024
This bill requires the Department of Health and Human Services to conduct an interagency review of lung cancer research, prevention, and awareness with respect to women and underserved populations.
The review must
- report on the status of existing research and current knowledge gaps;
- identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and
- provide recommendations for a national lung cancer screening strategy and public education campaign.
What's happening now
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committees of jurisdiction
3